Report Detail

Pharma & Healthcare Global Oncology Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2790926
  • |
  • 30 July, 2019
  • |
  • Global
  • |
  • 124 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Global Oncology Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

    1 Market Overview

    • 1.1 Oncology Drugs Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Antimetabolite
      • 1.2.2 Alkaloid drugs
      • 1.2.3 Hormone
      • 1.2.4 Targeted drug
      • 1.2.5 Platinum-based drugs
      • 1.2.6 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Blood Cancer
      • 1.3.2 Breast Cancer
      • 1.3.3 Gastrointestinal Cancer
      • 1.3.4 Prostate Cancer
      • 1.3.5 Respiratory/Lung Cancer
      • 1.3.6 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Nigeria Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Roche
      • 2.1.1 Business Overview
      • 2.1.2 Oncology Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Roche Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 HENGRUI
      • 2.2.1 Business Overview
      • 2.2.2 Oncology Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 HENGRUI Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 AstraZeneca
      • 2.3.1 Business Overview
      • 2.3.2 Oncology Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 AstraZeneca Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 QILU
      • 2.4.1 Business Overview
      • 2.4.2 Oncology Drugs Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 QILU Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Sanofi
      • 2.5.1 Business Overview
      • 2.5.2 Oncology Drugs Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Sanofi Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 HANSOH
      • 2.6.1 Business Overview
      • 2.6.2 Oncology Drugs Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 HANSOH Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 LUYE
      • 2.7.1 Business Overview
      • 2.7.2 Oncology Drugs Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 LUYE Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Novartis
      • 2.8.1 Business Overview
      • 2.8.2 Oncology Drugs Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Novartis Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 GuiZhou YiBai
      • 2.9.1 Business Overview
      • 2.9.2 Oncology Drugs Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 GuiZhou YiBai Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Lunan
      • 2.10.1 Business Overview
      • 2.10.2 Oncology Drugs Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Lunan Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Eli Lilly and Company
      • 2.11.1 Business Overview
      • 2.11.2 Oncology Drugs Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Eli Lilly and Company Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Oncology Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Oncology Drugs Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Oncology Drugs Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Oncology Drugs Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Oncology Drugs Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Oncology Drugs Market Analysis by Regions

    • 4.1 Global Oncology Drugs Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Oncology Drugs Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Oncology Drugs Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Oncology Drugs Sales and Growth Rate (2014-2019)
    • 4.3 Europe Oncology Drugs Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Oncology Drugs Sales and Growth Rate (2014-2019)
    • 4.5 South America Oncology Drugs Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Oncology Drugs Sales and Growth Rate (2014-2019)

    5 North America Oncology Drugs by Countries

    • 5.1 North America Oncology Drugs Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Oncology Drugs Sales and Market Share by Countries (2014-2019)
      • 5.1.2 North America Oncology Drugs Revenue and Market Share by Countries (2014-2019)
    • 5.2 United States Oncology Drugs Sales and Growth Rate (2014-2019)
    • 5.3 Canada Oncology Drugs Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Oncology Drugs Sales and Growth Rate (2014-2019)

    6 Europe Oncology Drugs by Countries

    • 6.1 Europe Oncology Drugs Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Oncology Drugs Sales and Market Share by Countries (2014-2019)
      • 6.1.2 Europe Oncology Drugs Revenue and Market Share by Countries (2014-2019)
    • 6.2 Germany Oncology Drugs Sales and Growth Rate (2014-2019)
    • 6.3 UK Oncology Drugs Sales and Growth Rate (2014-2019)
    • 6.4 France Oncology Drugs Sales and Growth Rate (2014-2019)
    • 6.5 Russia Oncology Drugs Sales and Growth Rate (2014-2019)
    • 6.6 Italy Oncology Drugs Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Oncology Drugs by Countries

    • 7.1 Asia-Pacific Oncology Drugs Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Oncology Drugs Sales and Market Share by Countries (2014-2019)
      • 7.1.2 Asia-Pacific Oncology Drugs Revenue and Market Share by Countries (2014-2019)
    • 7.2 China Oncology Drugs Sales and Growth Rate (2014-2019)
    • 7.3 Japan Oncology Drugs Sales and Growth Rate (2014-2019)
    • 7.4 Korea Oncology Drugs Sales and Growth Rate (2014-2019)
    • 7.5 India Oncology Drugs Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Oncology Drugs Sales and Growth Rate (2014-2019)

    8 South America Oncology Drugs by Countries

    • 8.1 South America Oncology Drugs Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Oncology Drugs Sales and Market Share by Countries (2014-2019)
      • 8.1.2 South America Oncology Drugs Revenue and Market Share by Countries (2014-2019)
    • 8.2 Brazil Oncology Drugs Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Oncology Drugs Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Oncology Drugs Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Oncology Drugs by Countries

    • 9.1 Middle East and Africa Oncology Drugs Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Oncology Drugs Sales and Market Share by Countries (2014-2019)
      • 9.1.2 Middle East and Africa Oncology Drugs Revenue and Market Share by Countries (2014-2019)
    • 9.2 Saudi Arabia Oncology Drugs Sales and Growth Rate (2014-2019)
    • 9.3 UAE Oncology Drugs Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Oncology Drugs Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Oncology Drugs Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Oncology Drugs Sales and Growth Rate (2014-2019)

    10 Global Oncology Drugs Market Segment by Type

    • 10.1 Global Oncology Drugs Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Oncology Drugs Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Oncology Drugs Revenue and Market Share by Type (2014-2019)
    • 10.2 Antimetabolite Sales Growth and Price
      • 10.2.1 Global Antimetabolite Sales Growth (2014-2019)
      • 10.2.2 Global Antimetabolite Price (2014-2019)
    • 10.3 Alkaloid drugs Sales Growth and Price
      • 10.3.1 Global Alkaloid drugs Sales Growth (2014-2019)
      • 10.3.2 Global Alkaloid drugs Price (2014-2019)
    • 10.4 Hormone Sales Growth and Price
      • 10.4.1 Global Hormone Sales Growth (2014-2019)
      • 10.4.2 Global Hormone Price (2014-2019)
    • 10.5 Targeted drug Sales Growth and Price
      • 10.5.1 Global Targeted drug Sales Growth (2014-2019)
      • 10.5.2 Global Targeted drug Price (2014-2019)
    • 10.6 Platinum-based drugs Sales Growth and Price
      • 10.6.1 Global Platinum-based drugs Sales Growth (2014-2019)
      • 10.6.2 Global Platinum-based drugs Price (2014-2019)
    • 10.7 Other Sales Growth and Price
      • 10.7.1 Global Other Sales Growth (2014-2019)
      • 10.7.2 Global Other Price (2014-2019)

    11 Global Oncology Drugs Market Segment by Application

    • 11.1 Global Oncology Drugs Sales Market Share by Application (2014-2019)
    • 11.2 Blood Cancer Sales Growth (2014-2019)
    • 11.3 Breast Cancer Sales Growth (2014-2019)
    • 11.4 Gastrointestinal Cancer Sales Growth (2014-2019)
    • 11.5 Prostate Cancer Sales Growth (2014-2019)
    • 11.6 Respiratory/Lung Cancer Sales Growth (2014-2019)
    • 11.7 Other Sales Growth (2014-2019)

    12 Oncology Drugs Market Forecast (2019-2024)

    • 12.1 Global Oncology Drugs Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Oncology Drugs Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Oncology Drugs Market Forecast (2019-2024)
      • 12.2.2 Europe Oncology Drugs Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Oncology Drugs Market Forecast (2019-2024)
      • 12.2.4 South America Oncology Drugs Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Oncology Drugs Market Forecast (2019-2024)
    • 12.3 Oncology Drugs Market Forecast by Type (2019-2024)
      • 12.3.1 Global Oncology Drugs Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Oncology Drugs Market Share Forecast by Type (2019-2024)
    • 12.4 Oncology Drugs Market Forecast by Application (2019-2024)
      • 12.4.1 Global Oncology Drugs Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Oncology Drugs Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

      Scope of the Report:
      Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer and Other Cancer Treatment. The most proportion of Oncology Drugs used for Blood Cancer and the proportion in 2017 is 22.74%.
      The worldwide market for Oncology Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Oncology Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Roche
      HENGRUI
      AstraZeneca
      QILU
      Sanofi
      HANSOH
      LUYE
      Novartis
      GuiZhou YiBai
      Lunan
      Eli Lilly and Company

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Antimetabolite
      Alkaloid drugs
      Hormone
      Targeted drug
      Platinum-based drugs
      Other

      Market Segment by Applications, can be divided into
      Blood Cancer
      Breast Cancer
      Gastrointestinal Cancer
      Prostate Cancer
      Respiratory/Lung Cancer
      Other

      There are 15 Chapters to deeply display the global Oncology Drugs market.
      Chapter 1, to describe Oncology Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
      Chapter 2, to analyze the top manufacturers of Oncology Drugs, with sales, revenue, and price of Oncology Drugs, in 2017 and 2018;
      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;
      Chapter 4, to show the global market by regions, with sales, revenue and market share of Oncology Drugs, for each region, from 2014 to 2019;
      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2014 to 2019;
      Chapter 12, Oncology Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
      Chapter 13, 14 and 15, to describe Oncology Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


      Summary:
      Get latest Market Research Reports on Oncology Drugs . Industry analysis & Market Report on Oncology Drugs is a syndicated market report, published as Global Oncology Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Oncology Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,857.78
      4,286.66
      5,715.55
      3,138.13
      4,707.19
      6,276.26
      370,606.08
      555,909.12
      741,212.16
      249,658.33
      374,487.50
      499,316.66
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report